Business
Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President
Carolyn Bonner Succeeds James ('Jim') Quinlan Who Has Resigned for Health Reasons After Taking Medical Leave in September 2025 PHILADELPHIA, PENNSYLVANIA /
About this update from Medicus Pharma Ltd.
[{"type":"text","content":"Carolyn Bonner Succeeds James ('Jim') Quinlan Who Has Resigned for Health Reasons After Taking Medical Leave in September 2025 PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / December 1, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) (\"Medicus\" or the \"Company\"), a precision guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, today announced that Carolyn Bonner, currently President of the Company, has also been appointed Chief Financial Officer, effective immediately. Bonner has been serving as Acting Chief Financial Officer since September 12, 2025, in addition to her responsibilities as President, providing continuity and leadership during the medical leave of departing Chief Financial Officer Jim Quinlan, who has now formally resigned for health reasons.\"Carolyn has been providing strong financial leadership since stepping in as acting CFO in September,\" stated Dr. Raza Bokhari, Medicus' Executive Chairman & CEO. \"Her appointment as CFO, in addition to President, enhances continuity, ensures stability and brings further alignment in our corporate objectives. These combined responsibilities also bring operational and financial integration under a single leader as Medicus advances its clinical development programs and expands its clinical pipeline.\"Dr. Bokhari also extended his gratitude to departing CFO Jim Quinlan on behalf of the Medicus Board and the entire Medicus team for his role as a co-founder of the Company, stating, \"Jim was mission-critical in our reverse takeover of Skinject, Inc., as well as the Company's initial public offering in the U.S. and listing on Nasdaq in November 2024.\"Proven Leadership in Healthcare, Life Sciences and Corporate DevelopmentMs. Bonner brings nearly 20 years of experience in the healthcare and life sciences sector, with a track record spanning executive leadership, corporate development, operations, and capital markets engagement.Before joining Medicus, she served as President & Chief Executive Officer of PCL, Inc., a CAP-accredited specialty laboratory with business operations in United States and United Arab Emirates.Prior to that, she held roles in business development and corporate development at Rosetta Genomics Ltd., a Nasdaq-listed molecular diagnostics company, and Inform Diagnostic...